Mechanistically, RBM15 promotes CC progression by installing m6A modification on the tumor suppressor DCN mRNA, thereby reducing DCN expression (Wang et al., 2025b); conversely, RBM15 silencing enhances DCN expression, while DCN depletion reverses this tumor-suppressive effect. The gene discussed is DCN; the disease is neoplasm.